↓ Skip to main content

When to start renal replacement therapy in critically ill patients with acute kidney injury: comment on AKIKI and ELAIN

Overview of attention for article published in Critical Care, August 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
55 X users
facebook
1 Facebook page

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
96 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
When to start renal replacement therapy in critically ill patients with acute kidney injury: comment on AKIKI and ELAIN
Published in
Critical Care, August 2016
DOI 10.1186/s13054-016-1424-0
Pubmed ID
Authors

Sean M. Bagshaw, François Lamontagne, Michael Joannidis, Ron Wald

Abstract

The dilemma of whether and when to start renal replacement therapy among critically ill patients with acute kidney injury in the absence of conventional indications has long been a vexing challenge for clinicians. The lack of high-quality evidence has undoubtedly contributed decisional uncertainty and unnecessary practice variation. Recently, two randomized trials (ELAIN and AKIKI) reported specifically on the issue of the timing of initiation of renal replacement therapy in critically ill patients with acute kidney injury. In this commentary, their fundamental differences in trial design, sample size, and widely discrepant findings are considered in context. While both trials are important contributions towards informing practice on this issue, additional evidence from large multicenter randomized trials is needed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 55 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Greece 1 1%
Italy 1 1%
South Africa 1 1%
Unknown 93 97%

Demographic breakdown

Readers by professional status Count As %
Other 19 20%
Student > Ph. D. Student 16 17%
Student > Postgraduate 15 16%
Professor 7 7%
Student > Master 7 7%
Other 19 20%
Unknown 13 14%
Readers by discipline Count As %
Medicine and Dentistry 69 72%
Nursing and Health Professions 2 2%
Mathematics 1 1%
Biochemistry, Genetics and Molecular Biology 1 1%
Psychology 1 1%
Other 3 3%
Unknown 19 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 31. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2019.
All research outputs
#1,302,717
of 25,646,963 outputs
Outputs from Critical Care
#1,102
of 6,599 outputs
Outputs of similar age
#24,627
of 382,491 outputs
Outputs of similar age from Critical Care
#43
of 107 outputs
Altmetric has tracked 25,646,963 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,599 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 382,491 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 107 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.